Craig Thompson, CEO of Cerevance touches on the NETSseq platform and how it shapes Cerevance's approach to the drug discovery strategy.
Craig Thompson
Advertisement
Articles by Craig Thompson
Craig Thompson, CEO of Cerevance discusses the key scientific and clinical insights that lead to Cerevance's pursuit of Solengepras.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
2
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
3
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
4
How Nuvation Bio Manages its Ongoing Clinical Trials
5